Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
(stem cell - proliferating cell - differentiating cell - senescing cell - to apoptosing cell. In this way, the follicular melanocyte location contrasts markedly with the epidermis, where melanocytes
-
applicant will have strong background in SKIN RESEARCH, wound healing, fibrosis or inflammatory disorders with technical expertise in induced pluripotent stem cells (iPSCs), immunology, cell biology or signal
-
biology, developmental biology, epigenetic mechanisms and molecular biological techniques, accompanied by demonstrated bioinformatic skills. Experience culturing trophoblast stem cells would be an asset
-
, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work experience or community service has prepared them
-
laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | about 19 hours ago
stem cell biology. In addition to clinical and academic departments, UTHSA is enriched by the Nathan Shock Center for Excellence in Biology of Aging, an NCI-designated Cancer Center, an NIH-funded
-
environmental and hormonal control of plant stem cell differentiation. You should be proficient in bulk and single-cell RNA-seq, ChIP-seq, and/or ATAC-seq analyses and standard bioinformatics pipelines
-
Assistant/Associate/Full Professor of Surgery – Genome Editing Delivery Expert UCSF Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research (Broad Center) Department of Surgery
-
; https://linkinghub.elsevier.com/retrieve/pii/S1937644817300825)vol. 335, pp. 41–84. What are the signals that determine innate immune memory? Supervisor: Ruaidhrí Carmody Project description: Cells
-
blood stem cells (e.g. Frömel et al., Cell 2025 ), and more translational projects in the context of acute myeloid leukemia (AML) and pre-leukemia (e.g. Beneyto-Calabuig et al., Cell Stem Cell 2023